{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:08:53Z","timestamp":1781154533379,"version":"3.54.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0011386","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000}}],"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"crossref","award":["261153"],"award-info":[{"award-number":["261153"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Consejo Nacional de Ciencia y Tecnolog\u00eda, MX","award":["272519"],"award-info":[{"award-number":["272519"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>The morbidity and mortality of extraparenchymal neurocysticercosis (EP-NC) remain high and effectiveness of current medical treatment is suboptimal. Various factors have been implicated in the severity of EP-NC and in the poor response to treatment, but the possible role of host immune and endocrine systems has not yet been examined thoroughly.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methodology\/Principal findings<\/jats:title>\n<jats:p>42 participants with EP-NC before receiving standard treatment and 25 healthy controls were included in the study. Treatment response was assessed by comparing pre\/post treatment parasite volumes from 3D MRI. Prior to treatment among participants with EP-NC, specific stimulation induced an increased specific proliferative response accompanied by a significant increase in IL-4, NK, NKT, Bregs and Tregs cells, whereas in healthy controls, specific stimulation induced a significant increase in IL-1\u03b2, IL-5, CCL5, IL-6, TNF-\u03b1, NK and Bregs cells. Significant differences between participants with EP-NC and healthy controls in the specific inflammatory response were observed. Participants with EP-NC prior to treatment had significantly weaker responses of proinflammatory cytokines (IL-6, TNF-\u03b1) and NK cells, and stronger IL-4 response. Anthelmintic treatment did not promote significant peripheral immunological changes at any time, although inflammation was sustained in the cerebrospinal fluid. Serum estradiol concentration significantly decreased after anthelmintic treatment among males, and cortisol correlated negatively with IL-6 and positively with IFN-\u03b3 levels. No pre-treatment immunologic or endocrinologic parameters were significantly associated with response to treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusion\/Significance<\/jats:title>\n<jats:p>Prior to anthelmintic treatment, EP-NC was characterized by low lymphocyte reactivity accompanied by a regulatory response, which may be involved in the lack of peripheral immunological changes during and after treatment, although a central inflammatory response was present. This weak specific peripheral response could favor the chronicity of the infection and the poor response to treatment. Our findings highlight the need for new anti-inflammatory treatment focused on the central nervous system with less systemic immunosuppressive effects.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0011386","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T17:32:05Z","timestamp":1685640725000},"page":"e0011386","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Low responsiveness of peripheral lymphocytes in extraparenchymal neurocysticercosis"],"prefix":"10.1371","volume":"17","author":[{"given":"Matthew L.","family":"Romo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Carrillo-Mezo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta C.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edda","family":"Sciutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladis","family":"Fragoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8930-2202","authenticated-orcid":true,"given":"Agn\u00e8s","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,6,1]]},"reference":[{"issue":"1","key":"pntd.0011386.ref001","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1586\/eri.10.150","article-title":"Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease","volume":"9","author":"A Fleury","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"pntd.0011386.ref002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4269\/ajtmh.20-1330","article-title":"Mortality in Parenchymal and Subarachnoid Neurocysticercosis","volume":"105","author":"J Abanto","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"pntd.0011386.ref003","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/jcph.1346","article-title":"Factors Associated With Cysticidal Treatment Response in Extraparenchymal Neurocysticercosis.","volume":"59","author":"R Osorio","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"pntd.0011386.ref004","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.3389\/fimmu.2018.02652","article-title":"Human Extraparenchymal Neurocysticercosis: The Control of Inflammation Favors the Host\u2026but Also the Parasite.","volume":"9","author":"A Toledo","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"pntd.0011386.ref005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00430-014-0345-2","article-title":"Neurocysticercosis: the effectiveness of the cysticidal treatment could be influenced by the host immunity","volume":"203","author":"G C\u00e1rdenas","year":"2014","journal-title":"Med Microbiol Immunol"},{"key":"pntd.0011386.ref006","doi-asserted-by":"crossref","first-page":"107801","DOI":"10.1016\/j.exppara.2019.107801","article-title":"Effect of dexamethasone on albendazole cysticidal activity in experimental cysticercosis by Taenia crassiceps in BALB\/c mice: In vitro and in vivo evaluation","volume":"208","author":"F Palomares-Alonso","year":"2020","journal-title":"Exp Parasitol"},{"issue":"12","key":"pntd.0011386.ref007","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1080\/14787210.2021.1912592","article-title":"Inflammation in neurocysticercosis: clinical relevance and impact on treatment decisions.","volume":"19","author":"PT Hamamoto Filho","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"pntd.0011386.ref008","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpara.2011.11.009","article-title":"Impact of Taenia solium neurocysticercosis upon endocrine status and its relation with immuno-inflammatory parameters","volume":"42","author":"G C\u00e1rdenas","year":"2012","journal-title":"Int J Parasitol"},{"key":"pntd.0011386.ref009","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fimmu.2018.00478","article-title":"Our Environment Shapes Us: The Importance of Environment and Sex Differences in Regulation of Autoantibody Production.","volume":"9","author":"M Edwards","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"pntd.0011386.ref010","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ana.24732","article-title":"New diagnostic criteria for neurocysticercosis: Reliability and validity","volume":"80","author":"A Carpio","year":"2016","journal-title":"Ann Neurol"},{"issue":"3","key":"pntd.0011386.ref011","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/01.wnl.0000195887.63124.dc","article-title":"Albendazole trial at 15 or 30 mg\/kg\/day for subarachnoid and intraventricular cysticercosis","volume":"66","author":"F Gongora-Rivera","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"pntd.0011386.ref012","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4269\/ajtmh.18-88751","article-title":"Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).","volume":"98","author":"AC White","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"pntd.0011386.ref013","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/14737175.2018.1518133","article-title":"New guidelines for the diagnosis and treatment of neurocysticercosis: a difficult proposal for patients in endemic countries","volume":"18","author":"A Carpio","year":"2018","journal-title":"Expert Rev Neurother."},{"key":"pntd.0011386.ref014","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.actatropica.2015.08.017","article-title":"Relevance of 3D magnetic resonance imaging sequences in diagnosing basal subarachnoid neurocysticercosis","volume":"152","author":"R Carrillo Mezo","year":"2015","journal-title":"Acta Trop"},{"issue":"4","key":"pntd.0011386.ref015","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.micinf.2005.11.005","article-title":"A depressed peripheral cellular immune response is related to symptomatic neurocysticercosis","volume":"8","author":"A Chavarria","year":"2006","journal-title":"Microbes and Infection"},{"issue":"1","key":"pntd.0011386.ref016","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4269\/ajtmh.19-0436","article-title":"Natural History of Treated Subarachnoid Neurocysticercosis","volume":"102","author":"TE Nash","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"pntd.0011386.ref017","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1708-8305.2011.00592.x","article-title":"Neurocysticercosis among international travelers to disease-endemic areas","volume":"19","author":"OH Del Brutto","year":"2012","journal-title":"J Travel Med."},{"issue":"9","key":"pntd.0011386.ref018","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1093\/cid\/ciaa1128","article-title":"The Local Inflammatory Profile and Predictors of Treatment Success in Subarachnoid Neurocysticercosis","volume":"72","author":"S Harrison","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1\u20132","key":"pntd.0011386.ref019","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2005.11.020","article-title":"Breakdown of the blood brain barrier and blood-cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC","volume":"173","author":"JI Alvarez","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"4","key":"pntd.0011386.ref020","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.exppara.2013.05.005","article-title":"Disruption of the blood-brain barrier in pigs naturally infected with Taenia solium, untreated and after anthelmintic treatment","volume":"134","author":"C Guerra-Giraldez","year":"2013","journal-title":"Exp Parasitol"},{"issue":"10","key":"pntd.0011386.ref021","doi-asserted-by":"crossref","first-page":"e0004143","DOI":"10.1371\/journal.pntd.0004143","article-title":"A Comparative Study of Peripheral Immune Responses to Taenia solium in Individuals with Parenchymal and Subarachnoid Neurocysticercosis","volume":"9","author":"I Tuero","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0011386.ref022","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1645\/GE-2839.1","article-title":"Human neurocysticercosis: in vivo expansion of peripheral regulatory T cells and their recruitment in the central nervous system","volume":"98","author":"L Adalid-Peralta","year":"2012","journal-title":"J Parasitol"},{"issue":"2","key":"pntd.0011386.ref023","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/cei.12709","article-title":"Interleukin 10 and dendritic cells are the main suppression mediators of regulatory T cells in human neurocysticercosis","volume":"183","author":"A Arce-Sillas","year":"2016","journal-title":"Clin Exp Immunol"},{"issue":"13","key":"pntd.0011386.ref024","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.ijpara.2005.06.003","article-title":"Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis","volume":"35","author":"LI Terrazas","year":"2005","journal-title":"Int J Parasitol"},{"issue":"4","key":"pntd.0011386.ref025","doi-asserted-by":"crossref","first-page":"e0008005","DOI":"10.1371\/journal.pntd.0008005","article-title":"Host immune responses during Taenia solium Neurocysticercosis infection and treatment.","volume":"14","author":"UF Prodjinotho","year":"2020","journal-title":"PLoSNegl Trop Dis."},{"issue":"21","key":"pntd.0011386.ref026","doi-asserted-by":"crossref","first-page":"10497","DOI":"10.1158\/0008-5472.CAN-06-1908","article-title":"Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-gamma and inhibit tumor growth","volume":"66","author":"UI Chaudhry","year":"2006","journal-title":"Cancer Res"},{"key":"pntd.0011386.ref027","first-page":"2395645","article-title":"Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis","volume":"2016","author":"JQ Yang","year":"2016","journal-title":"J Immunol Res"},{"issue":"2","key":"pntd.0011386.ref028","first-page":"143","article-title":"Cerebral infarct precipitated by praziquantel in neurocysticercosis\u2014a cautionary note","volume":"40","author":"E Woo","year":"1988","journal-title":"Trop Geogr Med"},{"issue":"1","key":"pntd.0011386.ref029","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.STR.28.1.211","article-title":"Large cerebral infarction during praziquantel therapy in neurocysticercosis","volume":"28","author":"OY Bang","year":"1997","journal-title":"Stroke"},{"issue":"6","key":"pntd.0011386.ref030","doi-asserted-by":"crossref","first-page":"e0005624","DOI":"10.1371\/journal.pntd.0005624","article-title":"Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.","volume":"11","author":"C Cangalaya","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0011386.ref031","author":"World Health Organization","year":"2021","journal-title":"WHO guidelines on management of Taenia solium neurocysticercosis"},{"key":"pntd.0011386.ref032","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jsbmb.2005.04.020","article-title":"Aromatase in testis: expression and role in male reproduction","volume":"95","author":"S Lambard","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"2","key":"pntd.0011386.ref033","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/bcr425","article-title":"The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer","volume":"4","author":"A Purohit","year":"2002","journal-title":"Breast Cancer Res"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0011386","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T17:35:03Z","timestamp":1686677703000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011386"}},"subtitle":[],"editor":[{"given":"Uriel","family":"Koziol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,6,1]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0011386","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0011386","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,1]]}}}